Ticagrelor

Details

Files

Generic Name:

Ticagrelor

Project Status:

Cancelled

Therapeutic Area:

Acute Coronary Syndromes

Manufacturer:

AstraZeneca Canada Inc

Call for patient/clinician input open:

June 8, 2010

Brand Name:

Brilinta

Project Line:

Reimbursement Review

Project Number:

SR0203-000

Call for patient/clinician input closed:

June 30, 2010

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Acute Coronary Syndromes (ACS)

Files

Submission Status Report View PDF

Last Updated : June 8, 2010